Partial-onset Seizures
📧 Sign up to get email alerts when something new happens for Partial-onset Seizures.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS)
Post-marketing study evaluating eslicarbazepine acetate as an adjunctive treatment for partial-onset seizures; the EPOS trial (E2093-E044-40…
-
CLINICAL_TRIALS trial_result · 2015-03-02Clinical Trial Update: A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures [Phase 2]
A Phase 2 cognition study of levetiracetam in children with partial-onset seizures has completed (19-week evaluation).
-
CLINICAL_TRIALS trial_result · 2015-02-11Clinical Trial Update: A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures [Phase 3]
A double-blind, confirmatory Phase 3 trial of levetiracetam in patients with partial-onset seizures has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures [Phase 3]
Phase 3 trial evaluating adjunctive lacosamide in adults with partial-onset seizures has completed and results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset Seizures [Phase 2]
Phase 2 study evaluating the cognitive effects of eslicarbazepine acetate in children with partial-onset seizures; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy [Phase 3]
Phase 3 open-label study assessing levetiracetam monotherapy in patients with newly diagnosed focal epilepsy.
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizures [Phase 3]
A Phase 3 trial evaluating two doses of immediate-release retigabine (900 mg/day and 600 mg/day) as adjunctive therapy in adult Asian subjec…
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures [Phase 3]
Phase 3 study evaluating USL255 for refractory partial-onset seizures has completed. Results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures [Phase 4]
A Phase 4 trial evaluated lacosamide as the first add-on antiseizure medication for patients with partial-onset seizures; results were poste…
-
CLINICAL_TRIALS trial_result · 2014-04-23Clinical Trial Update: Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures [Phase 3]
Phase 3 trial results evaluate converting to lacosamide monotherapy for partial-onset seizures, reporting on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures [Phase 3]
Phase 3 study evaluating adjunctive topiramate in infants aged 1–24 months for partial-onset seizures has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Dose-Optimization, Adjunctive Treatment Study of Ezogabine/Retigabine Immediate Release in Partial-onset Seizures [Phase 4]
Phase 4 dose-optimization study of ezogabine/retigabine IR as adjunctive treatment in partial-onset seizures was terminated; results posted …
-
CLINICAL_TRIALS trial_result · 2014-01-24Clinical Trial Update: Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures [Phase 2, Phase 3]
Phase 2/3 trial evaluating the efficacy, safety and tolerability of TRI476 (oxcarbazepine) in children with inadequately controlled partial …
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS [Phase 3]
A Phase 3 double-blind, placebo-controlled trial evaluating levetiracetam in adults with partial-onset seizures has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-10Clinical Trial Update: Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures [Phase 3]
A Phase 3 trial evaluating eslicarbazepine acetate as add-on therapy for refractory partial seizures reported efficacy and safety results; t…
-
CLINICAL_TRIALS trial_result · 2013-08-08Clinical Trial Update: Belgian Drug-utilization Study to Evaluate the Use of VIMPAT® as Adjunctive Treatment of Partial Onset Seizures in Subjects Aged 16 and Older
A completed clinical trial assessed lacosamide (VIMPAT) as adjunctive therapy for adults with partial-onset seizures; results were posted in…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures [Phase 2]
An open-label Phase 2 study evaluating intravenous L059 in Japanese patients with epilepsy and partial onset seizures completed, with result…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures. [Phase 3]
Phase 3 trial updating on the effectiveness, safety, and tolerability of carisbamate as add-on therapy for partial-onset seizures. The study…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure [Phase 4]
The document reports the completion of a Phase 4 trial evaluating optimized dosing of lacosamide as add-on therapy for partial onset seizure…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures [Phase 3]
A Phase 3 trial evaluating RWJ-333369 as adjunctive therapy for partial onset seizures in Korean and Japanese patients was terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Long Term Effectiveness and Safety Study for RWJ-333369 as Adjunctive Therapy in Korean and Japanese Patients With Partial Onset Seizures [Phase 3]
This clinical trial update notes the completion of a Phase 3 long-term effectiveness and safety study of RWJ-333369 as adjunctive therapy fo…
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study) [Phase 3]
Phase 3 trial assessing the efficacy and safety of adjunctive zonisamide in pediatric patients with partial-onset seizures; results were pos…
-
CLINICAL_TRIALS trial_result · 2012-11-22Clinical Trial Update: To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures [Phase 3]
Phase 3 trial results update for perampanel (E2007) as adjunctive therapy in refractory partial-onset seizures, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-06-20Clinical Trial Update: A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of RWJ-333369 as add-on therapy for partial-onset seizures; the study has complete…
-
CLINICAL_TRIALS trial_result · 2012-06-18Clinical Trial Update: A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. [Phase 3]
Phase 3 study evaluating RWJ-333369 as add-on therapy for partial onset seizures in epilepsy, assessing efficacy and safety. The trial statu…